HS

HS HYOSUNG Corporation

A holding company for advanced materials, AI/data solutions, mobility, and global logistics.

487570 | KO

Overview

Corporate Details

ISIN(s):
KR7487570004
LEI:
Country:
South Korea
Address:
서울특별시 마포구 마포대로 119 (공덕동), 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

HS HYOSUNG Corporation is a holding company operating across four core business sectors: Advanced Materials, AI/Data Solutions, Mobility, and Supply Chain Management (SCM). The Advanced Materials division is a leading producer of high-tech materials, including PET tire cords and carbon fiber, through subsidiaries like HS HYOSUNG ADVANCED MATERIALS. The AI/Data Solutions segment, led by HS HYOSUNG INFORMATION SYSTEMS, provides integrated cloud infrastructure, AI platforms, and storage technology. Its Mobility division offers premium automotive and mobility solutions, while the SCM arm delivers optimized global logistics services. The company's mission is to create value and contribute to a better future through continuous technological development and innovation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Related Party Transaction
[기재정정]금전대여결정(자회사의 주요경영사항)
Korean 22.1 KB
2025-09-17 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 117.1 KB
2025-09-17 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 55.3 KB
2025-09-12 00:00
Capital/Financing Update
타인에대한채무보증결정(자회사의 주요경영사항)
Korean 22.6 KB
2025-08-29 00:00
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 15.3 KB
2025-08-18 00:00
Related Party Transaction
타인에대한채무보증결정(자회사의 주요경영사항)
Korean 22.8 KB
2025-08-14 00:00
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.2 KB
2025-08-14 00:00
Related Party Transaction
동일인등출자계열회사와의상품ㆍ용역거래변경
Korean 19.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.6 MB
2025-07-31 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.8 KB
2025-07-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 108.1 KB
2025-07-04 00:00
M&A Activity
[기재정정]영업양도결정(종속회사의주요경영사항)
Korean 15.9 KB
2025-06-04 00:00
Capital/Financing Update
타인에대한채무보증결정(자회사의 주요경영사항)
Korean 22.3 KB
2025-06-02 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 184.2 KB
2025-05-30 00:00
M&A Activity
영업양도결정(종속회사의주요경영사항)
Korean 11.7 KB

Automate Your Workflow. Get a real-time feed of all HS HYOSUNG Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HS HYOSUNG Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HS HYOSUNG Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.